PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Why Human empathy still matters in the age of AI

2025-06-30
(Press-News.org) A new study finds that people value empathy more when they believe it comes from a human—even if the actual response was generated by AI. Across nine studies involving over 6,000 participants, the research reveals that human-attributed responses are perceived as more supportive, more emotionally resonant, and more caring than identical AI-generated responses.

A new international study led by Prof Anat Perry from the Hebrew University of Jerusalem and her PhD student – Matan Rubin, in collaboration with Prof. Amit Goldenberg researchers from Harvard University and Prof. Desmond C. Ong from the University of Texas, finds that people place greater emotional value on empathy they believe comes from humans—even when the exact same response is generated by artificial intelligence.

Published in Nature Human Behaviour, the study involved over 6,000 participants across nine experiments. The researchers tested whether people perceived empathy differently depending on whether it was labeled as coming from a human or from an AI chatbot. In all cases, the responses were crafted by large language models (LLMs), yet participants consistently rated the “human” responses as more empathic, more supportive, and more emotionally satisfying than the identical “AI” responses.

“We’re entering an age where AI can produce responses that look and sound empathic,” said Prof. Perry. “But this research shows that even if AI can simulate empathy, people still prefer to feel that another human truly understands, feels with them, and cares.”

The preference was especially strong for responses that emphasized emotional sharing and genuine care—the affective and motivational components of empathy—rather than just cognitive understanding. In fact, participants were even willing to wait days or weeks to receive a response from a human rather than get an immediate reply from a chatbot.

Interestingly, when participants believed an AI may have helped generate or edit a response they thought was from a human, their positive feelings diminished significantly. This suggests that perceived authenticity—believing that someone genuinely invested time and emotional effort—plays a critical role in how we experience empathy.

“In today’s world, it’s becoming second nature to run our emails or messages through AI,” said Prof. Perry. “But our findings suggest a hidden cost: the more we rely on AI, the more our words risk feeling hollow. As people begin to assume that every message is AI-generated, the perceived sincerity, and with it, the emotional connection, may begin to disappear.”

While AI shows promise for use in education, healthcare, and mental health settings, the study highlights its limitations. “AI may help scale support systems,” Perry explains, “but in moments that require deep emotional connection, people still want the human touch.”

The study offers key insights into the psychology of empathy and raises timely questions about how society will integrate emotionally intelligent AI into our daily lives.

END


ELSE PRESS RELEASES FROM THIS DATE:

COVID-19 and cognitive change in a community-based cohort

2025-06-30
About The Study: This cohort study of older participants found accelerated decreases in cognition among individuals hospitalized for SARS-CoV-2 infection, but not nonhospitalized infection, in comparison with individuals not yet infected. These findings suggest that avoiding severe SARS-CoV-2 infection could help preserve cognitive function among older adults.  Corresponding Authors: To contact the corresponding authors, email Ryan T. Demmer, PhD, MPH, (demmer.ryan@mayo.edu) and Elizabeth C. Oelsner, MD, DrPH, (eco7@cumc.columbia.edu). To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2025.18648) Editor’s ...

Intent to test for COVID-19 in the postpandemic era

2025-06-30
About The Study: Nearly one-third of U.S. adults would not or might not test for suspected COVID-19, largely because they do not see value in testing, according to the results of an online national survey. Test hesitancy may delay oral antiviral initiation and could result in missed opportunities to limit transmission. Efforts are needed to increase awareness of the value of testing.  Corresponding Author: To contact the corresponding author, Kimberly A. Fisher, MD, email kimberly.fisher2@umassmed.edu. To access the embargoed study: Visit our For The Media website at this ...

Landmark study investigates potential of Ambroxol, a cough medicine, to slow Parkinson’s-related dementia

2025-06-30
LONDON, Ont. – Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph’s Health Care London, are investigating whether Ambroxol - a cough medicine used safely for decades in Europe - can slow dementia in people with Parkinson’s disease. Published today in the prestigious JAMA Neurology, this 12-month clinical trial involving 55 participants with Parkinson’s disease dementia (PDD) monitored memory, psychiatric symptoms and GFAP, a blood marker linked to ...

Finding suggests treatment approach for autoimmune diseases

2025-06-30
An engineered protein turns off the kind of immune cells most likely to damage tissue as part of Type-1 diabetes, hepatitis, multiple sclerosis, shows a new study in mice.   In these autoimmune diseases, T cells mistakenly target the body’s own tissues instead of invading viruses or bacteria as they would during normal immune responses. Treatments focused on T cells have been elusive because blocking their action broadly weakens the immune system and creates risk for infections and cancer. Published online June 30 in the journal Cell, the study revealed that holding closely together two protein groups (signaling complexes) on ...

A new “link” to triple-negative breast cancer

2025-06-30
Breast cancer is one of the most common cancers among women in the United States. Thanks to decades of fundamental research, it’s also one of the most curable. The exception is a particularly aggressive variant known as triple-negative breast cancer (TNBC). It accounts for 10 to 15 percent of all breast cancer cases. It disproportionately affects younger and African American women. No effective therapies exist. A new discovery by Cold Spring Harbor Laboratory Professor David Spector and graduate student Wenbo Xu—published in Molecular Cancer Research, a journal of the American Association for Cancer Research—could help ...

Cool is cool wherever you are

2025-06-30
From Chile to China, cultures vary greatly around the globe, but people in at least a dozen countries agree about what it means to be cool, according to research published by the American Psychological Association.    The researchers conducted experiments with almost 6,000 participants from countries around the world and found that cool people have surprisingly similar personalities. Even though Eastern and Western cultures often differ in many cultural attitudes, cool people were universally perceived to be more extraverted, hedonistic, powerful, adventurous, open and autonomous.  “Everyone wants to be cool, or at least ...

Meteorological satellites observe temperatures on Venus

2025-06-30
Imaging data from Japan’s Himawari-8 and -9 meteorological satellites have been successfully used to monitor temporal changes in Venus’ cloud-top temperature, revealing unseen patterns in the temperature structure of various waves. A team led by the University of Tokyo collated infrared images from 2015–25 to estimate brightness temperatures on day to year scales. The results demonstrate that meteorological satellites can serve as additional eyes to access the Venusian atmosphere from space ...

New hope for brain cancer: FAU awarded grants for glioblastoma treatment

2025-06-30
Florida Atlantic University researchers have secured two key grants to investigate targeting a gene for the first time as a new approach to treat glioblastoma, a very aggressive and fast-growing type of brain cancer.   Malignant gliomas, such as glioblastoma multiforme and astrocytomas, are the most common type of primary brain tumor in the United States. They make up about 78% of all malignant brain tumors. Although these tumors are not very common, especially in the U.S., they cause a high number of cancer deaths because they are so aggressive. These awards, granted by the Florida Department of Health’s Cancer Connect program for $562,000 and the Palm Health Foundation for ...

AI for Good Global Summit 2025 - Exclusive press tour (ITU/United Nations)

2025-06-30
The United Nations' digital tech agency, ITU, invites reporters to an exclusive press tour on Monday, 7 July, before the official opening of the AI for Good Global Summit 2025. With the rapid advance of artificial intelligence – from autonomous AI agents to brain-machine interfaces, self-driving vehicles, and a growing range of quantum technologies – AI for Good highlights global AI action to safeguard the future.​ AI for Good will feature talks from AI leaders and 100+ demos showcasing AI innovations to deliver ...

Bacteria hijack tick cell defenses to spread disease

2025-06-30
PULLMAN, Wash. – Washington State University researchers have discovered how the bacteria that cause anaplasmosis and Lyme disease hijack cellular processes in ticks to ensure their survival and spread to new hosts, including humans. Based in the College of Veterinary Medicine, the team found that the bacteria can manipulate a protein known as ATF6, which helps cells detect and respond to infection, to support its own growth and survival inside the tick. The findings, published in the journal Proceedings of the National Academy of Sciences, could serve as a launching point for developing methods to eliminate the bacteria in ticks before they are transmitted to humans and ...

LAST 30 PRESS RELEASES:

5 advances to protect water sources, availability

OU Scholar awarded Fulbright for Soviet cinema research

Brain might become target of new type 1 diabetes treatments

‘Shore Wars:’ New research aims to resolve coastal conflict between oysters and mangroves, aiding restoration efforts

Why do symptoms linger in some people after an infection? A conversation on post-acute infection syndromes

Study reveals hidden drivers of asthma flare-ups in children

Physicists decode mysterious membrane behavior

New insights about brain receptor may pave way for next-gen mental health drugs

Melanoma ‘sat-nav’ discovery could help curb metastasis

When immune commanders misfire: new insights into rheumatoid arthritis inflammation

SFU researchers develop a new tool that brings blender-like lighting control to any photograph

Pups in tow, Yellowstone-area wolves trek long distances to stay near prey

AI breakthrough unlocks 'new' materials to replace lithium-ion batteries

Making molecules make sense: A regional explanation method reveals structure–property relationships

Partisan hostility, not just policy, drives U.S. protests

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: August 1, 2025

Young human blood serum factors show potential to rejuvenate skin through bone marrow

Large language models reshape the future of task planning

Narrower coverage of MS drugs tied to higher relapse risk

Researchers harness AI-powered protein design to enhance T-cell based immunotherapies

Smartphone engagement during school hours among US youths

Online reviews of health care facilities

MS may begin far earlier than previously thought

New AI tool learns to read medical images with far less data

Announcing XPRIZE Healthspan as Tier 5 Sponsor of ARDD 2025

Announcing Immortal Dragons as Tier 4 Sponsor of ARDD 2025

Reporting guideline for chatbot health advice studies

Announcing Mitra Bio as Tier 3 Sponsor of ARDD 2025

Study identifies global upswing in photosynthesis driven by land, offset by oceans

Study reports final clinical trial data for advanced kidney cancer treatment

[Press-News.org] Why Human empathy still matters in the age of AI